The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Denby William C since 2006.
The trader's CIK number is 1279193.
At the time of the last reporting, Denby William C was the Sr. VP, Commercial O of Adamis Pharmaceuticals Corp. (stock ticker symbol ADMP).
Also see all insider trading activities at Adamis Pharmaceuticals Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | ADMP | 6,250 | $10,000 | 0 | $0 | 0 | $0 |
| 2014 | ADMP | 2,500 | $12,642 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | SNTS | 0 | $0 | 220,650 | $4,306,766 | 251,561 | $448,202 |
| 2010 | SNTS | 0 | $0 | 15,747 | $70,283 | 0 | $0 |
| 2009 | SNTS | 0 | $0 | 20,996 | $88,497 | 10,000 | $8,750 |
| 2008 | SNTS | 0 | $0 | 0 | $0 | 25,000 | $21,875 |
| 2007 | SNTS | 0 | $0 | 27,000 | $190,360 | 25,000 | $26,250 |
| 2006 | SNTS | 0 | $0 | 40,500 | $281,284 | 0 | $0 |
1. Adamis Pharmaceuticals Corp (ADMP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-24 | ADMP | Buy | 6,250 | 1.60 | 10,000 |
| 2014-09-02 | ADMP | Buy | 2,500 | 5.06 | 12,642 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-10-31 | SNTS | Option Ex | 30,472 | 2.36 | 71,913 |
| 2013-10-01 | SNTS | Sale | 24,450 | 23.03 | 563,059 |
| 2013-10-01 | SNTS | Option Ex | 24,450 | 1.18 | 28,851 |
| 2013-05-14 | SNTS | Option Ex | 26,695 | 1.18 | 31,500 |
| 2013-09-03 | SNTS | Option Ex | 24,450 | 1.18 | 28,851 |
| 2013-09-03 | SNTS | Sale | 24,450 | 22.43 | 548,462 |
| 2013-08-01 | SNTS | Option Ex | 24,450 | 1.18 | 28,851 |
| 2013-08-01 | SNTS | Sale | 24,450 | 24.77 | 605,626 |
| 2013-07-01 | SNTS | Option Ex | 25,050 | 2.34 | 58,617 |
| 2013-07-01 | SNTS | Sale | 25,050 | 21.56 | 540,027 |
| 2013-06-03 | SNTS | Option Ex | 24,450 | 3.50 | 85,575 |
| 2013-06-03 | SNTS | Sale | 24,450 | 21.46 | 524,623 |
| 2013-05-01 | SNTS | Sale | 24,450 | 17.90 | 437,630 |
| 2013-05-01 | SNTS | Option Ex | 19,598 | 3.50 | 68,593 |
| 2013-04-01 | SNTS | Option Ex | 3,046 | .88 | 2,665 |
| 2013-04-01 | SNTS | Sale | 24,450 | 17.75 | 433,987 |
| 2013-03-01 | SNTS | Sale | 24,450 | 13.38 | 327,165 |
| 2013-03-01 | SNTS | Option Ex | 24,450 | .88 | 21,393 |
| 2013-02-01 | SNTS | Option Ex | 24,450 | .88 | 21,393 |
| 2013-02-01 | SNTS | Sale | 24,450 | 13.34 | 326,187 |
| 2010-03-15 | SNTS | Sale | 5,249 | 4.68 | 24,565 |
| 2010-02-17 | SNTS | Sale | 5,249 | 4.00 | 20,996 |
| 2010-01-15 | SNTS | Sale | 5,249 | 4.71 | 24,722 |
| 2009-12-15 | SNTS | Sale | 5,249 | 4.76 | 24,985 |
| 2009-11-16 | SNTS | Sale | 5,249 | 4.10 | 21,520 |
| 2009-11-11 | SNTS | Sale | 10,498 | 4.00 | 41,992 |
| 2009-02-19 | SNTS | Option Ex | 10,000 | .88 | 8,750 |
| 2008-10-23 | SNTS | Option Ex | 25,000 | .88 | 21,875 |
| 2007-09-17 | SNTS | Option Ex | 25,000 | 1.05 | 26,250 |
| 2007-05-15 | SNTS | Sale | 5,400 | 6.32 | 34,101 |
| 2007-04-16 | SNTS | Sale | 5,400 | 7.78 | 41,990 |
| 2007-03-15 | SNTS | Sale | 5,400 | 6.59 | 35,586 |
| 2007-02-15 | SNTS | Sale | 5,400 | 6.99 | 37,746 |
| 2007-01-16 | SNTS | Sale | 5,400 | 7.58 | 40,937 |
| 2006-10-16 | SNTS | Sale | 4,500 | 8.36 | 37,602 |
| 2006-09-15 | SNTS | Sale | 4,500 | 8.24 | 37,089 |
| 2006-08-15 | SNTS | Sale | 4,500 | 6.28 | 28,260 |
| 2006-07-20 | SNTS | Sale | 2,681 | 6.00 | 16,086 |
| 2006-07-17 | SNTS | Sale | 1,819 | 6.00 | 10,923 |
| 2006-05-15 | SNTS | Sale | 4,500 | 6.99 | 31,432 |
| 2006-04-17 | SNTS | Sale | 4,500 | 7.92 | 35,653 |
| 2006-03-15 | SNTS | Sale | 4,500 | 6.27 | 28,214 |
| 2006-02-15 | SNTS | Sale | 4,500 | 6.45 | 29,025 |
| 2006-01-26 | SNTS | Sale | 4,500 | 6.00 | 27,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Denby William C (Sr. VP, Commercial O of Adamis Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.